Valuation: Yuhan Corporation

Market Cap 5,161B 3.49B 3.06B 2.83B 2.6B 4.91B 337B 4.99B 33.81B 13.25B 165B 13.1B 12.82B 567B P/E 2026 *
38.4x
P/E 2027 * 24.9x
Enterprise Value 5.07B 3.43M 3M 2.78M 2.55M 4.82M 330M 4.9M 33.2M 13.01M 162M 12.87M 12.59M 557M EV / Sales 2026 *
2.17x
EV / Sales 2027 * 1.93x
Free-Float
64.28%
Yield 2026 *
0.8%
Yield 2027 * 0.81%
1 day-2.26%
1 week+1.02%
Current month-1.42%
1 month-9.07%
3 months-29.03%
6 months-34.66%
Current year-38.43%
1 week 66,200
Extreme 66200
71,300
1 month 65,000
Extreme 65000
75,900
Current year 65,000
Extreme 65000
115,900
1 year 65,000
Extreme 65000
134,800
3 years 52,285.71
Extreme 52285.7143
166,900
5 years 47,571.43
Extreme 47571.4286
166,900
10 years 24,550.49
Extreme 24550.4865
166,900
Manager TitleAgeSince
Chief Executive Officer 71 2021-03-18
Director of Finance/CFO 58 -
President 67 2024-03-14
Director TitleAgeSince
Chairman 74 2021-03-18
Director/Board Member 71 2015-03-19
Director/Board Member 62 2020-02-29
Date Insider Type Main position Quantity % Market Cap.
6/30/25 Buy

Chairperson

200 0.0002%
6/25/25 Buy

Chief Executive Officer

720 0.0009%
6/24/25 Buy 231 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-2.26%+1.02%-47.58%+21.10% 3.55B
-1.48%+1.30%+58.42%+15.84% 315B
-0.99%-3.50%+22.91%-10.98% 67.81B
-0.37%+1.99%+38.81%+82.35% 9.23B
+0.34%+0.51%+5.21%-1.87% 8.56B
-3.27%-6.80%-25.44%-5.88% 4.18B
+0.12%-11.96%-7.91%+16.33% 3.59B
-0.23%+1.18%+44.18%+56.31% 2.79B
+3.79%+1.33%+7.85%-21.52% 2.09B
+3.01%+3.79%-19.92%+33.35% 1.83B
Average -0.14%-1.47%+7.65%+18.50% 41.85B
Weighted average by Cap. -1.28%+1.91%+48.15%+12.59%

Financials

2026 *2027 *
Net sales 2,333B 1.58B 1.38B 1.28B 1.18B 2.22B 152B 2.25B 15.28B 5.99B 74.43B 5.92B 5.79B 256B 2,586B 1.75B 1.53B 1.42B 1.3B 2.46B 169B 2.5B 16.94B 6.64B 82.5B 6.57B 6.42B 284B
Net income 141B 95.63M 83.82M 77.48M 71.26M 134M 9.22B 137M 926M 363M 4.51B 359M 351M 15.55B 212B 144M 126M 116M 107M 202M 13.84B 205M 1.39B 545M 6.77B 539M 527M 23.33B
Net Debt -93.37B -63.14M -55.34M -51.16M -47.05M -88.77M -6.09B -90.2M -612M -240M -2.98B -237M -232M -10.26B -158B -107M -93.45M -86.38M -79.44M -150M -10.28B -152M -1.03B -405M -5.03B -400M -392M -17.33B
Logo Yuhan Corporation
Yuhan Corp is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Business segment manufactures and sells non-prescription drugs, such as analgesics, anti-inflammatory drugs, probiotics, nutritional supplements, and wound-healing agents, as well as prescription drugs, including treatments for diabetes, hyperlipidemia, hypertension, hepatitis, acquired immunodeficiency syndrome (AIDS), bone marrow cancer, cough suppressants, and breast cancer. The Overseas Business segment engages in the export of AIDS treatment intermediates. The Healthcare Business segment provides household goods, such as bleach. Additionally, the Company sells licenses. The Company sells its products in both domestic and overseas markets.
Employees
2,087
Date Price Change Volume
26-07-19 69,200.00 -2.26% 178,034
26-07-16 ₩70,800.00 +1.87% 245,221
26-07-15 ₩69,500.00 +4.20% 279,742
26-07-14 ₩66,700.00 -2.06% 295,357
26-07-13 ₩68,100.00 -0.58% 267,788
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
70,800.00KRW
Average target price
127,555.56KRW
Spread / Average Target
+80.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A000100 Stock